24/7 Customer Support
Valsad, Gujarat, India
WHO-GMP certified fluconazole 400mg tablets for high-dose antifungal therapy and critical infections with comprehensive global export capabilities.
| Strength | 400mg |
| Dosage Form | Tablets |
| Route | Oral |
| Indications | Critical infections, high-dose therapy, invasive candidiasis |
| HS Code | 3004.20.90 |
| Regulatory Support | WHO-GMP, ISO 9001, CTD/eCTD dossier |
| Shelf Life | 24-36 months |
| Storage | Room temperature |
| Packaging Options | 10×10 blister packs, 30s, 100s, hospital packs |
| Target Markets | Critical care units, tertiary hospitals, specialty centers |
Maximum potency formulation for life-threatening systemic fungal infections requiring aggressive therapeutic intervention.
High-dose therapy for invasive candidiasis and other severe fungal infections in immunocompromised patients.
Optimized for patients requiring maximum drug exposure for effective treatment of complex fungal infections.
Valid WHO-GMP certification for international market access
Detailed COA with complete quality parameters
ICH-compliant stability studies for all climate zones
Complete registration dossier for global submissions
Contact our export team for competitive pricing, regulatory support, and seamless global supply chain solutions.